67 related articles for article (PubMed ID: 6439801)
1. [A statistical study of management based on prognostic factors after surgical treatment for cervical carcinoma].
Maeda T; Okamura S; Ueki M
Nihon Sanka Fujinka Gakkai Zasshi; 1984 Nov; 36(11):2106-14. PubMed ID: 6439801
[TBL] [Abstract][Full Text] [Related]
2. [Analysis of prognostic factors in patients with cervical squamous cell carcinoma of stage Ib and IIa].
Chen L; Lü WG; Xie X; Chen HZ; Yu H; Ni XH
Zhonghua Fu Chan Ke Za Zhi; 2005 Apr; 40(4):239-42. PubMed ID: 15924669
[TBL] [Abstract][Full Text] [Related]
3. The prognostic factors for patients with early cervical cancer treated by radical hysterectomy and postoperative radiotherapy.
Tsai CS; Lai CH; Wang CC; Chang JT; Chang TC; Tseng CJ; Hong JH
Gynecol Oncol; 1999 Dec; 75(3):328-33. PubMed ID: 10600284
[TBL] [Abstract][Full Text] [Related]
4. Ten-year survival of patients with locally advanced, stage ib-iib cervical cancer after neoadjuvant chemotherapy and radical hysterectomy.
Hwang YY; Moon H; Cho SH; Kim KT; Moon YJ; Kim SR; Kim DS
Gynecol Oncol; 2001 Jul; 82(1):88-93. PubMed ID: 11426967
[TBL] [Abstract][Full Text] [Related]
5. [Differing progress patterns in cancer of the uterine cervix and variant effects of adjuvant chemotherapy based on histological type].
Sugawa T; Yamagata S
Gan To Kagaku Ryoho; 1986 Feb; 13(2):210-5. PubMed ID: 3080962
[TBL] [Abstract][Full Text] [Related]
6. Cervical cancer: combined modality therapy.
Grigsby PW
Cancer J; 2001; 7 Suppl 1():S47-50. PubMed ID: 11504285
[TBL] [Abstract][Full Text] [Related]
7. Histopathological findings in postoperative specimens in cervical cancer patients with stages IB2-IVA after neoadjuvant chemotherapy and preoperative plus postoperative radiotherapy.
Kornovski Y; Gorchev G
J BUON; 2007; 12(1):57-63. PubMed ID: 17436403
[TBL] [Abstract][Full Text] [Related]
8. A comparison of prognoses of pathologic stage Ib adenocarcinoma and squamous cell carcinoma of the uterine cervix.
Nakanishi T; Ishikawa H; Suzuki Y; Inoue T; Nakamura S; Kuzuya K
Gynecol Oncol; 2000 Nov; 79(2):289-93. PubMed ID: 11063659
[TBL] [Abstract][Full Text] [Related]
9. [Prognostic factors of stage IB and IIA carcinoma of the cervix treated by surgery].
Zhang WH; Wu LY; Bai P; Li SM; Zhang R; Li B; Sun JH; Wu AR
Zhonghua Zhong Liu Za Zhi; 2004 Aug; 26(8):490-2. PubMed ID: 15555341
[TBL] [Abstract][Full Text] [Related]
10. Surgical pathologic factors that predict recurrence in stage IB and IIA cervical carcinoma patients with negative pelvic lymph nodes.
Samlal RA; van der Velden J; Ten Kate FJ; Schilthuis MS; Hart AA; Lammes FB
Cancer; 1997 Oct; 80(7):1234-40. PubMed ID: 9317173
[TBL] [Abstract][Full Text] [Related]
11. Neoadjuvant chemotherapy in stage IB2 squamous cell carcinoma of the cervix.
Serur E; Mathews RP; Gates J; Levine P; Maiman M; Remy JC
Gynecol Oncol; 1997 May; 65(2):348-56. PubMed ID: 9159350
[TBL] [Abstract][Full Text] [Related]
12. [Lymphatic metastasis in patients with invasive cervical carcinoma after initial treatment].
Lou HM; Li Q
Ai Zheng; 2007 Nov; 26(11):1248-51. PubMed ID: 17991327
[TBL] [Abstract][Full Text] [Related]
13. [Studies on oral-adjuvant chemotherapy of uterine cervical cancer after surgical treatment].
Maeda T
Nihon Sanka Fujinka Gakkai Zasshi; 1986 Sep; 38(9):1515-26. PubMed ID: 3095465
[TBL] [Abstract][Full Text] [Related]
14. Adenosquamous carcinoma versus adenocarcinoma in early-stage cervical cancer patients undergoing radical hysterectomy: an outcomes analysis.
dos Reis R; Frumovitz M; Milam MR; Capp E; Sun CC; Coleman RL; Ramirez PT
Gynecol Oncol; 2007 Dec; 107(3):458-63. PubMed ID: 17854872
[TBL] [Abstract][Full Text] [Related]
15. Treatment of maxillary sinus carcinoma: a comparison of the 1997 and 1977 American Joint Committee on cancer staging systems.
Le QT; Fu KK; Kaplan M; Terris DJ; Fee WE; Goffinet DR
Cancer; 1999 Nov; 86(9):1700-11. PubMed ID: 10547542
[TBL] [Abstract][Full Text] [Related]
16. Prognostic factors in surgically treated stage ib-iib cervical carcinomas with special emphasis on the importance of tumor volume.
Trattner M; Graf AH; Lax S; Forstner R; Dandachi N; Haas J; Pickel H; Reich O; Staudach A; Winter R
Gynecol Oncol; 2001 Jul; 82(1):11-6. PubMed ID: 11426955
[TBL] [Abstract][Full Text] [Related]
17. Long-term follow-up results of irradiation alone or combined with surgery in stage I-IV carcinoma of the uterine cervix.
Reinartz G; Bartsch S; Willich N
Zentralbl Gynakol; 2000; 122(6):318-23. PubMed ID: 10904995
[TBL] [Abstract][Full Text] [Related]
18. [Multivariate statistical analysis of the postoperative recurrence factors in uterine cervical carcinoma].
Ito T; Yago H; Kuribayashi M; Osawa H
Nihon Sanka Fujinka Gakkai Zasshi; 1988 Mar; 40(3):338-44. PubMed ID: 3361186
[TBL] [Abstract][Full Text] [Related]
19. Identification of histopathologic risk groups in stage IB squamous cell carcinoma of the cervix.
Gauthier P; Gore I; Shingleton HM; Soong SJ; Orr JW; Hatch KD
Obstet Gynecol; 1985 Oct; 66(4):569-74. PubMed ID: 4047545
[TBL] [Abstract][Full Text] [Related]
20. Neoadjuvant chemotherapy with vincristine and cisplatin followed by radical hysterectomy and pelvic lymphadenectomy for FIGO stage IB bulky cervical cancer: a Gynecologic Oncology Group pilot study.
Eddy GL; Manetta A; Alvarez RD; Williams L; Creasman WT
Gynecol Oncol; 1995 Jun; 57(3):412-6. PubMed ID: 7774847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]